Liquid Biopsy Accurately Detects Key Genetic Mutations in Most Common Form of Lung Cancer
Study demonstrates the test’s potential as a clinical tool for identifying patients who can benefit from drugs targeting specific mutations.
Read MoreSearch Results for: lung cancer
New Data May Help Physicians Better Understand Risk of Lung Cancer
University of Missouri study identifies more precise probability of cancer diagnosis.
Read More
Largest-Ever Randomized Trial for Lung Cancer Biomarkers Yields Promising Early Results
The Early Cancer Detection Test-Lung Cancer Scotland study is designed to determine whether use of the Oncimmune blood test leads to earlier detection of lung cancer and can help to save lives in the long term.
Read MoreLung Cancer Target Selector Assay Featured at World Conference on Lung Cancer
Clinical data show the utility of Biocept’s liquid biopsy assay in therapeutic management of patients with non-small cell lung cancer.
Read More
Targeted Liquid Biopsy Mutation Test for Advanced Lung Cancer Launched
The GeneStrat test by Biodesix reveals actionable NSCLC mutations, returning results within 72 hours.
Read More